FR2382450A1 - Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols - Google Patents

Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols

Info

Publication number
FR2382450A1
FR2382450A1 FR7806161A FR7806161A FR2382450A1 FR 2382450 A1 FR2382450 A1 FR 2382450A1 FR 7806161 A FR7806161 A FR 7806161A FR 7806161 A FR7806161 A FR 7806161A FR 2382450 A1 FR2382450 A1 FR 2382450A1
Authority
FR
France
Prior art keywords
agents
pyridine
thiols
application
training
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7806161A
Other languages
English (en)
Other versions
FR2382450B1 (fr
Inventor
Jan Per Erik Carlsson
Rolf Erik Axel Verner Axen
Hakan Nils Yngve Drevin
Goran Einar Samuel Lindgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Pharmacia Fine Chemicals AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Fine Chemicals AB filed Critical Pharmacia Fine Chemicals AB
Publication of FR2382450A1 publication Critical patent/FR2382450A1/fr
Application granted granted Critical
Publication of FR2382450B1 publication Critical patent/FR2382450B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polyamides (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composés de la pyridine. Ces composés correspondent à la formule générale :
FR7806161A 1977-03-04 1978-03-03 Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols Granted FR2382450A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7702462A SE430062B (sv) 1977-03-04 1977-03-04 Kopplings- eller tioleringsreagens

Publications (2)

Publication Number Publication Date
FR2382450A1 true FR2382450A1 (fr) 1978-09-29
FR2382450B1 FR2382450B1 (fr) 1982-11-05

Family

ID=20330623

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7806161A Granted FR2382450A1 (fr) 1977-03-04 1978-03-03 Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols

Country Status (6)

Country Link
US (1) US4149003A (fr)
JP (2) JPS53130674A (fr)
DE (1) DE2808523A1 (fr)
FR (1) FR2382450A1 (fr)
GB (1) GB1597756A (fr)
SE (1) SE430062B (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
FR2446287A1 (fr) * 1979-01-12 1980-08-08 Toyo Jozo Kk Nouveau compose disulfure polyfonctionnel
EP0064040A1 (fr) * 1981-04-06 1982-11-03 Pharmacia Aktiebolag Dérivés disulfure thérapeutiquement actifs et leur emploi
EP0074271A1 (fr) * 1981-09-08 1983-03-16 Ortho Diagnostic Systems Inc. Liaison de deux anticorps
WO1983002946A1 (fr) * 1982-02-26 1983-09-01 Relyveld, Edgar, Hans Agents antitumoraux, tels que la daunorubicine a efficacite amelioree, leur obtention et procede pour augmenter l'efficacite des agents antitumoraux
EP0234600A1 (fr) * 1983-02-25 1987-09-02 The Upjohn Company Composés pour réactions de liaison des paires ligand-récepteur
EP0240200A2 (fr) * 1986-03-17 1987-10-07 Cetus Corporation Agents de réticulation, leur usage et leur préparation
EP0283563A2 (fr) * 1983-12-24 1988-09-28 Beecham Group Plc Nouveaux dérivés
EP0405578A2 (fr) * 1989-06-29 1991-01-02 Nippon Shoji Kabushiki Kaisha Immunoessai enzymatique pour détecter les antigènes et phase solide pour sa mise en oeuvre
EP0457250A2 (fr) * 1990-05-14 1991-11-21 Bristol-Myers Squibb Company Composés de liaison bifonctionnels, conjugués et leur procédé de production

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8003732L (sv) * 1980-05-19 1981-11-20 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
US4563304A (en) * 1981-02-27 1986-01-07 Pharmacia Fine Chemicals Ab Pyridine compounds modifying proteins, polypeptides or polysaccharides
SE8102194L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
SE8302758L (sv) * 1983-05-17 1984-11-18 Pharmacia Ab Sett for uppspjelkning av disulfidbindningar och derigenom erhallen forening
EP0184701B1 (fr) * 1984-12-03 1994-06-08 Hoechst Celanese Corporation Procédé pour déterminer un ligand
US4880935A (en) * 1986-07-11 1989-11-14 Icrf (Patents) Limited Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
JPS6391563A (ja) * 1986-10-07 1988-04-22 Nitsusui Seiyaku Kk 細菌由来蛋白特異抗原の検査法
US4798795A (en) * 1987-02-17 1989-01-17 Hoechst Celanese Corporation Biotinylating agents
US4794082A (en) * 1987-02-17 1988-12-27 Hoechst Celanese Corporation Biotinylating agents
US4709037A (en) * 1987-02-17 1987-11-24 Hoechst Celanese Corporation Biotinylating agents
JPS63189278U (fr) * 1987-05-28 1988-12-05
DE3809986A1 (de) * 1988-03-24 1989-10-05 Boehringer Mannheim Gmbh Verbindungen zur einfuehrung einer sh-gruppe in tyrosin
JPH0253770U (fr) * 1988-10-12 1990-04-18
WO1992001938A1 (fr) * 1990-07-20 1992-02-06 City Of Hope Derivatisation de proline a terminaison c
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
US6552060B1 (en) 1997-08-11 2003-04-22 Prolx Pharmaceuticals, Inc. Asymmetric disulfides and methods of using same
US20030176512A1 (en) * 1998-08-11 2003-09-18 Kirkpatrick D. Lynn Asymmetric disulfides and methods of using same
AR030612A1 (es) * 2000-09-12 2003-08-27 Smithkline Beecham Corp Procedimiento e intermedios
AU2003259163B2 (en) * 2002-08-16 2008-07-03 Immunogen, Inc. Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
WO2004037310A2 (fr) 2002-10-21 2004-05-06 Allvivo, Inc. Revetement de surface comprenant un compose bioactif
US7858108B2 (en) 2003-10-21 2010-12-28 Richard Nagler Elutable surface coating
CA2570321C (fr) * 2004-07-02 2013-10-08 Genentech, Inc. Inhibiteurs de pai
CA2591148A1 (fr) 2004-12-09 2006-06-15 Centocor, Inc. Immunoconjugues anti-integrines, methodes et applications
EA019420B1 (ru) 2004-12-20 2014-03-31 Дженентех, Инк. Пирролидиновые ингибиторы иап (ингибиторов апоптоза)
US20110166319A1 (en) * 2005-02-11 2011-07-07 Immunogen, Inc. Process for preparing purified drug conjugates
ES2503719T3 (es) 2005-02-11 2014-10-07 Immunogen, Inc. Procedimiento para preparar conjugados de anticuerpos y de maitansinoides
PL1928503T3 (pl) 2005-08-24 2012-12-31 Immunogen Inc Sposób wytwarzania koniugatów majtazynoid-przeciwciało
US8247557B2 (en) * 2005-12-19 2012-08-21 Genentech, Inc. IAP inhibitors
US20070260041A1 (en) * 2006-05-03 2007-11-08 David Crich Allylic disulfide rearrangement and desulfurization method for the preparation of allylic sulfides
CA2671607A1 (fr) * 2006-12-19 2008-07-03 Genentech, Inc. Inhibiteurs imidazopyridine de iap
JP5368428B2 (ja) * 2007-04-30 2013-12-18 ジェネンテック， インコーポレイテッド Ｉａｐのインヒビター
RU2010133548A (ru) * 2008-01-11 2012-02-20 Дженентек, Инк. (Us) Ингибиторы iap
JP2011529962A (ja) 2008-08-02 2011-12-15 ジェネンテック， インコーポレイテッド Ｉａｐのインヒビター
SG176068A1 (en) 2009-06-03 2011-12-29 Immunogen Inc Conjugation methods
RS58367B1 (sr) 2011-03-29 2019-03-29 Immunogen Inc Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
IN2015DN03202A (fr) 2012-10-04 2015-10-02 Immunogen Inc
US9518017B2 (en) 2013-06-28 2016-12-13 Immunogen, Inc. Purification of intermediates used in the preparation of heterobifunctional linkers
KR102325753B1 (ko) 2019-12-20 2021-11-11 주식회사 포스코 흑색 도금 강판 및 그 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872450A (en) * 1955-12-06 1959-02-03 Bayer Ag Thio- and dithio-carboxylic acid esters and a process for their manufacture
US3950348A (en) * 1971-12-30 1976-04-13 Merck & Co., Inc. Process for preparing e-pyridyl-4-methyloxycarbonyllysine

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
FR2446287A1 (fr) * 1979-01-12 1980-08-08 Toyo Jozo Kk Nouveau compose disulfure polyfonctionnel
EP0064040A1 (fr) * 1981-04-06 1982-11-03 Pharmacia Aktiebolag Dérivés disulfure thérapeutiquement actifs et leur emploi
EP0074271A1 (fr) * 1981-09-08 1983-03-16 Ortho Diagnostic Systems Inc. Liaison de deux anticorps
WO1983002946A1 (fr) * 1982-02-26 1983-09-01 Relyveld, Edgar, Hans Agents antitumoraux, tels que la daunorubicine a efficacite amelioree, leur obtention et procede pour augmenter l'efficacite des agents antitumoraux
FR2522269A1 (fr) * 1982-02-26 1983-09-02 Pasteur Institut Agents antitumoraux, tels que la daunorubicine, a efficacite amelioree, leur obtention et procede pour augmenter l'efficacite des agents antitumoraux
EP0088022A1 (fr) * 1982-02-26 1983-09-07 Institut Pasteur Agents antitumoraux à efficacité améliorée, leur obtention et procédé pour augmenter l'efficacité des agents antitumoraux
US4625019A (en) * 1982-02-26 1986-11-25 Institut Pasteur Polymeric product of daunorubicin and glutaraldehyde
EP0234600A1 (fr) * 1983-02-25 1987-09-02 The Upjohn Company Composés pour réactions de liaison des paires ligand-récepteur
EP0283563A2 (fr) * 1983-12-24 1988-09-28 Beecham Group Plc Nouveaux dérivés
EP0283563A3 (en) * 1983-12-24 1988-11-23 Beecham Group Plc Novel derivatives
EP0240200A2 (fr) * 1986-03-17 1987-10-07 Cetus Corporation Agents de réticulation, leur usage et leur préparation
EP0240200A3 (fr) * 1986-03-17 1990-03-28 Cetus Corporation Agents de réticulation, leur usage et leur préparation
EP0405578A2 (fr) * 1989-06-29 1991-01-02 Nippon Shoji Kabushiki Kaisha Immunoessai enzymatique pour détecter les antigènes et phase solide pour sa mise en oeuvre
EP0405578A3 (en) * 1989-06-29 1991-05-29 Nippon Shoji Kabushiki Kaisha Enzyme immunoassay for antigen and solid phase used therefor
EP0620438A1 (fr) * 1989-06-29 1994-10-19 Nippon Shoji Kabushiki Kaisha Immunoessai enzymatique pour détecter les antigènes et phase solide pour sa mise en oeuvre
EP0457250A2 (fr) * 1990-05-14 1991-11-21 Bristol-Myers Squibb Company Composés de liaison bifonctionnels, conjugués et leur procédé de production
EP0457250A3 (en) * 1990-05-14 1992-07-01 Bristol-Myers Squibb Company Novel bifunctional linking compounds, conjugates and methods for their production

Also Published As

Publication number Publication date
SE7702462L (sv) 1978-09-05
DE2808523C2 (fr) 1987-11-19
JPS624368B2 (fr) 1987-01-30
JPS6121227B2 (fr) 1986-05-26
FR2382450B1 (fr) 1982-11-05
JPS61191675A (ja) 1986-08-26
US4149003A (en) 1979-04-10
JPS53130674A (en) 1978-11-14
DE2808523A1 (de) 1978-09-07
GB1597756A (en) 1981-09-09
SE430062B (sv) 1983-10-17

Similar Documents

Publication Publication Date Title
FR2382450A1 (fr) Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols
FR2387954A1 (fr) Derives de mercaptoalkylsulfonylproline et composes apparentes, et leur utilisation comme medicaments
FR2391183A1 (fr) Hydroxyalkylphenones et leur application comme photosensibilisateurs
FR2377377A1 (fr) Amides derives du trimethoxy-3,4,5 benzene et leur application comme medicaments
FR2390420A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2377418A1 (fr) Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
FR2445323A2 (fr) Amides d'alkylenediamines et leur application en therapeutique
FR2422643A1 (fr) Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments
FR2391209A1 (fr) Aminoalkyl thiophenes, utiles comme medicaments, leur preparation et compositions en contenant
FR2432511A1 (fr) Derives triazoliques, leur preparation et leur application en tant que medicaments
FR2401135A1 (fr) Nouveaux derives d'aminoalkyl-benzenes et procedes pour leur preparation
FR2387988A1 (fr) Esters de cefuroxime, leur preparation et leur application therapeutique
FR2436149A1 (fr) Nouveaux aminoglucosides, leur preparation et leur application comme medicaments
FR2390446A1 (fr) Nouvelles triazines 1,3,5-s-hexahydrotrisubstituees, leur preparation et leur application a la lutte contre le developpement microbien
FR2423485A1 (fr) Nouvelles 1,3-diaryl-2-imino-imidazolidines et 1,3-diaryl-2-imino-hexahydro-pyrimidines substituees, procedes de preparation de ces composes et medicaments les contenant
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2395994A1 (fr) Nouveaux derives d'aminoacides a-acetyleniques et leur utilisation therapeutique
FR2382449A1 (fr) Halogenures de dithienylalkyle, leur preparation et leur application comme produits intermediaires dans la preparation de dithienylalkylamines
FR2401935A1 (fr) Nouveaux 25-alkylcholesterols utiles notamment comme hypocholesterolemiants et leur procede de preparation
FR2355831A1 (fr) Derives de benzazocine, leur procede de preparation et leur application therapeutique
FR2399465A1 (fr) Nouveaux complexes chromiferes 1 : 2, leur preparation et leur application comme colorants
FR2433536A1 (fr) Nouveaux derives de l'androst 4-ene, leur procede de preparation et leur application comme medicament
FR2432513A1 (fr) Nouveaux derives de la thiazoline et leur application comme medicaments
FR2433017A1 (fr) Derives de la phtalazone-1 et medicaments qui en contiennent
FR2433516A1 (fr) Pyridoxines, leur preparation et leurs utilisations therapeutiques

Legal Events

Date Code Title Description
ST Notification of lapse